Exploring Lysosomal dysfunction in Neuronal Ceroid Lipofuscinosis Investigador: Maria do Carmo Macário The loss of progranulin (PGRN) expression has been directly linked with neurodegeneration in the form of neuronal ceroid lipofuscinosis 11 (NCL11), a lysosomal storage disease observed in homozygous GRN mutation carriers, or frontotemporal lobar degeneration (FTLD), an early-onset dementia present in individuals with heterozygous mutations in this gene. We recently identified a NCL11 patient bearing a homozygous GRN mutation which is one of three described cases in the world and the first one identified as a member of a family with several cases of FTLD with genetic and neuropathological confirmation. Despite recent efforts, it is still unclear how alterations in PGRN levels contribute to neuronal loss in this two pathologies, which have completely different phenotypes.
|
The effect of Globotriaosylceramide on invariant Natural Killer T cell activation Investigador: Maria de Fátima Macedo Fabry disease is a lysosomal storage disease (LSD) characterized by the accumulation of globotriaosylceramide (Gb3). The aim of this project is to investigate whether Gb3 is a regulator of the immune response through a direct effect in Invariant Natural Killer T (iNKT) cell regulation, which may contribute to the definition of a new mechanism explaining the iNKT cell abnormalities found in other LSDs. |
Development of a U1 snRNA-adapted gene therapeutic strategy to correct 5’ splicing defects in lysosomal storage disorders Investigador: Liliana Matos In this work, an antisense-snRNA therapeutic strategy will be developed for mutations present in Mucopolysaccharidosis 1 and Mucolipidosis III patients. |
Molecular and cellular defects of cystatin B – from cell to population Investigador: Ana Joana Duarte Este trabalho foca-se na caracterização mutacional do gene Cystatin B na população Portuguesa e identificação da distribuíção subcelular da Cystatin B em doentes com a doença de Unverricht-Lundborg, de modo a melhor compreender a sua patofisiologia. |
Cytokine production by inkt cells in Fabry disease Investigador: Maria de Fátima Macedo O objetivo deste projeto é determinar a produção de citocinas pelas células iNKT e subpopulações de células iNKT em doentes com doença de Fabry, bem como no modelo animal de doença de Fabry. O apoio financeiro concedido por este prémio contribuiu para o trabalho apresentado na seguinte publicação:
|
CONTACTOS
Faculdade de Farmácia da U.L.
Av. Prof. Gama Pinto
1649-003 Lisboa
Portugal
Contacto: Fernanda Asper
Telefone.: +351 217 946 400
(Chamada para a rede fixa nacional)
Fax: +351 217 946 491
spdm@ff.ul.pt
Subscreva a newsletter da SPDM - Sociedade Portuguesa de Doenças Metabólicas
Newsletter